Growth Metrics

Nephros (NEPH) Shares Outstanding (Diluted Average) (2022 - 2025)

Nephros has reported Shares Outstanding (Diluted Average) over the past 9 years, most recently at $11.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $11.0 million for Q4 2025, up 3.45% from a year ago — trailing twelve months through Dec 2025 was $11.0 million (up 3.45% YoY), and the annual figure for FY2025 was $11.0 million, up 3.45%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $11.0 million at Nephros, up from $10.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for NEPH hit a ceiling of $11.0 million in Q4 2025 and a floor of $10.3 million in Q2 2022.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $10.5 million (2024), compared with a mean of $10.5 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 0.31% in 2023 and later rose 3.45% in 2025.
  • Nephros' Shares Outstanding (Diluted Average) stood at $10.3 million in 2022, then increased by 0.86% to $10.4 million in 2023, then rose by 2.08% to $10.6 million in 2024, then rose by 3.45% to $11.0 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $11.0 million (Q4 2025), $10.8 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.